from the august/05 nomura figure (up to the time of the german order) we know the forecast sale (which must hv been verified with gsk before publication) was gbp20m=aud35m for 2005. extrapolate from the nomura figure add french/aus orders and other suspects you are looking at min aud$50-65m for 2005.
http://www.newratings.com/analyst_news/article_981662.html
GlaxoSmithKline's Relenza Sales Seen GBP20M
Tuesday, August 23, 2005 3:22:44 AM ET
Dow Jones Newswires
0715 GMT [Dow Jones] Nomura says GlaxoSmithKline (GSK) has limited supply of Relenza flu product. Notes company is planning to scale up production substantially, but adds current production process involves several outside parties and a lead time of around 12 months. Sales of Relenza could, however, reach GBP20M this year with the recently announced 1.7M dose contract with the German government (pl see abv link for full article)
- Forums
- ASX - By Stock
- BTA
- relenza production
relenza production, page-3
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online